| Name | Alenvir Tablet |
| Company Name | Square Pharmaceuticals Ltd. |
| Power | 25 mg |
| Group | Tenofovir Alafenamide |
| Unit Price | ৳ 90.00 |
| Pack Price | 10’s pack: ৳ 900.00 |
| Indications |
Tenofovir Alafenamide is a hepatitis B virus (HBV) nucleoside analog reverse transcriptase inhibitor and is indicated for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease.
|
| Dosage & Administration | Testing Prior To Initiation Of Tenofovir Alafenamide: Prior to initiation of Tenofovir Alafenamide, patients should be tested for HIV-1 infection. Tenofovir Alafenamide alone should not be used in patients with HIV infection
It is recommended that serum creatinine, serum phosphorous, estimated creatinine clearance, urine glucose, and urine protein be assessed before initiating Tenofovir Alafenamide and during therapy in all patients as clinically appropriate Recommended Dosage In Adults: The recommended dosage of Tenofovir Alafenamide is 25 mg (one tablet) taken orally once daily with food |
| Side Effects | The following adverse reactions are discussed in other sections of the labeling:
The most common side effects are headache, stomach pain, tiredness, cough, nausea, back pain |
| Overdose Effects | If overdose occurs, monitor patient for evidence of toxicity. Treatment of overdosage with Tenofovir Alafenamide consists of general supportive measures including monitoring of vital signs as well as observation of the clinical status of the patient. Tenofovir is efficiently removed by hemodialysiswith an extraction coefficient of approximately 54% |
| Storage Conditions | Store below 86°F (30°C). Keep in its original container. Keep the container tightly closed. |
Alenvir Tablet 25 mg
